About Simira Unipath Diagnostics Private Limited
Data last updated:
Simira Unipath Diagnostics Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 03 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85190MH2020PTC335458.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.54 Lakh. It is led by directors including Jwalant Sureshbhai Shah and Aruna Santosh Wakchaure.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sector 17, Panvel, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.78 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹4.72 Cr (net margin -32%) and EBITDA of -₹2.37 Cr (EBITDA margin -16%). Revenue has grown at a compounded annual rate (CAGR) of 508% over three years.
The company has about 129 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Simira Diagnostics. As per MCA filings, the company has open charges of ₹94.24 Lakh and satisfied charges of ₹1.72 Cr on record.
For more details, the company can be reached via its website simiradiagnostics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. 405 Bhoomi Landmark Chs, Plot No. 34/35A Sector 17 Khanda Colony, Panvel, Maharashtra, India – 410206
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics operates one associated brand: Simira Diagnostics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic services including pathology tests and health checkups in Navi Mumbai. | simiradiagnostics.com |
Business Activity of Simira Unipath Diagnostics Private Limited
The main business activity of Simira Unipath Diagnostics is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Simira Unipath Diagnostics Private Limited FY 2024 filings available
Simira Unipath Diagnostics Private Limited reported revenue of ₹14.78 Cr (up 30% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Simira Unipath Diagnostics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 508% over three years, including 30% growth in the latest year. EBITDA fell 490% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Simira Unipath Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.37 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.72 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Simira Unipath Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -16% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -32% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Simira Unipath Diagnostics are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jwalant Sureshbhai Shah | Director | 06 Jan 2024 | 2 Years 9 Months | Current |
| Aruna Santosh Wakchaure | Director | 16 May 2023 | 3 Years 5 Months | Current |
| Santosh Wakchaure | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison of Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prism Bio-Medicals Private Limited | ₹15.26 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Bangalore, Karnataka, India |
| Joy Imaging Private Limited | ₹15.18 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Divine Scan Private Limited | ₹15.03 Cr (FY 2025) | •••• | •••• | •••• | Junagadh, Gujarat, India | |
| Dr. Chaudhary Hospital and Medical Research Centre P. Ltd. | ₹14.95 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Udaipur (Raj.), Rajasthan, India |
| Millennium Special Lab Private Limited | ₹14.9 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Thane, Maharashtra, India |
| Simira Unipath Diagnostics Private Limited this company | ₹14.78 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Panvel, Maharashtra, India |
| Deeptek Medical Services Private Limited | ₹14.76 Cr (FY 2024) | •••• | •••• | 102.0% | •••• | Pune, Maharashtra, India |
| Radolabs Limited | ₹14.72 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Chennai, Tamil Nadu, India |
| L7h Life Resources Private Limited | ₹14.65 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Bangalore, Karnataka, India |
| Multispeciality Lab Services Private Limited | ₹14.39 Cr (FY 2021) | •••• | •••• | -2.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
| Neuberg Magnum Imaging & Diagnostics Private Limited | ₹14.36 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Simira Unipath Diagnostics by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics Private Limited is audited by RAHUL B AGARWAL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAHUL B AGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Simira Unipath Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Simira Unipath Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2023 | Others | ₹50 Lakh | Open |
| 25 Apr 2023 | Others | ₹26.24 Lakh | Open |
| 22 Jun 2022 | Others | ₹18 Lakh | Open |
| 06 Apr 2023 | Tjsb Sahakari Bank Limited | ₹17.82 Lakh | Satisfied |
| 26 Aug 2022 | Tjsb Sahakari Bank Limited | ₹26.93 Lakh | Satisfied |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics Private Limited has a workforce of 129 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Simira Dhamke Private Limited | U85300MH2021PTC360768 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Jwalant Sureshbhai Shah ceased to be Additional Director on 25 Feb 2024.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Simira Unipath Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Simira Unipath Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Simira Unipath Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Simira Unipath Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Simira Unipath Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simira Unipath Diagnostics Private Limited
Simira Unipath Diagnostics is an active private limited company based in Panvel, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 03 January 2020 (6+ years old) and is registered under CIN U85190MH2020PTC335458.
Simira Unipath Diagnostics reported revenue of ₹14.78 Cr for FY 2024 (up 30% YoY).
Simira Unipath Diagnostics has 3 current directors:
- Jwalant Sureshbhai Shah - Director
- Aruna Santosh Wakchaure - Director
- Santosh Wakchaure - Director
Simira Unipath Diagnostics reported a net loss of ₹4.72 Cr (net margin -32%) and EBITDA of -₹2.37 Cr (EBITDA margin -16%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Simira Unipath Diagnostics is 508% over three years. In the latest year (FY 2024) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Simira Unipath Diagnostics is U85190MH2020PTC335458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Simira Unipath Diagnostics was incorporated on 03 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Simira Unipath Diagnostics by revenue are Prism Bio-Medicals Private Limited, Joy Imaging Private Limited, Divine Scan Private Limited, Dr. Chaudhary Hospital and Medical Research Centre P. Ltd, Millennium Special Lab Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Jwalant Sureshbhai Shah ceased to be Additional Director on 25 Feb 2024. Ganesh Uttam Wakchaure ceased to be Director on 06 Jan 2024. Jwalant Sureshbhai Shah was appointed as Director on 06 Jan 2024. Simira Unipath Diagnostics has 6 board changes on record in total.
Simira Unipath Diagnostics can be reached through the website simiradiagnostics.com. Its registered office is in Panvel, Maharashtra, India.
The registered office of Simira Unipath Diagnostics is at Office No. 405 Bhoomi Landmark Chs, Plot No. 3435A Sector 17 Khanda Colony, Panvel, Maharashtra, India – 410206.